School of Pharmacy

Publications in the Biomolecular Science and Medicinal Chemistry Division

Publications

Content
CHAN, W.C., ATKINSON, G.E., COWAN, A., MCINNES, C. and FISCHER, P.M., 2002. p21(WAF1)-derived octapeptide inhibitors of CDK-cyclin complex: The effect of structural variants of the C-terminal Phe residue Journal of Peptide Science. 8, S146

Content
CHAN, W.C. and HIGTON, A., 2002. Amino acids. In: Amino acids, Peptides and Proteins 33. Cambridge University Press, Cambridge, UK. 1-82

Content
DREVENY, INGRID, KRATKY, CHRISTOPH and GRUBER, KARL, 2002. The active site of hydroxynitrile lyase from Prunus amygdalus: modeling studies provide new insights into the mechanism of cyanogenesis. Protein Science. 11(2), 292-300

Content
HEALD,C.R., STOLNIK-TRENKIC,S., KUJAWINSKI,K.S., DEMATTEIS,C., GARNETT,M.C., ILLUM,L., DAVIS,S.S., PURKISS,S.C., BARLOW,R.J. and GELLERT,P.R., 2002. Poly(lactic acid)-poly(ethylene oxide) (PLA-PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG corona Langmuir. 18(9), 3669-3675

Content
DE MATTEIS, C.I., 2002. Small Matters - a series of short films

Content
WELLS, G., BERRY, J.M., BRADSHAW, T.D., MATTHEWS, C.S., STEVENS, M.F., WESTWELL, A.D. and VASSELIN, D., 2002. Novel lead antitumour structures from oxygenated and hydroxylated bicyclic heterocycles British Journal of Cancer. 86(1), S117

Content
WESTWELL, A.D., WELLS, G., BERRY, J.M., BRADSHAW, T.D., BURGER, A.M., MATTHEWS, C.S. and STEVENS, M.F., 2002. Synthesis of heteroaromatic quinols, novel agents with selective activity clustered in colon and renal cell lines Proceedings of the American Association for Cancer Research. 43, 1034

Content
STEVENS, M.F., WELLS, G., BRADSHAW, T.D., WESTWELL, A.D. and HOLBECK, S.L., 2002. The use of the COMPARE algorithm to guide mechanistic studies on novel antitumour agents Proceedings of the American Association for Cancer Research. 43, 4731

Content
MUKHERJEE, A., MARTIN, S., BRADSHAW, T.D., WESTWELL, A.D. and CARMICHAEL, J., 2002. In vitro antitumour and antiangiogenic activity of AW 464 (NSC 706704), a novel quinol British Journal of Cancer. 86(1), S108-S109

Content
BRADSHAW, T D, CHUA, M-S, BROWNE, H L, TRAPANI, V, SAUSVILLE, E A and STEVENS, M F G, 2002. In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles. British Journal of Cancer. 86(8), 1348-54

Content
BRADSHAW, T D, TRAPANI, V, VASSELIN, D A and WESTWELL, A D, 2002. The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe? Current Pharmaceutical Design. 8(27), 2475-90

Content
BRADSHAW, TRACEY D, BIBBY, MICHAEL C, DOUBLE, JOHN A, FICHTNER, IDUNA, COOPER, PATRICIA A, ALLEY, MICHAEL C, DONOHUE, SUSAN, STINSON, SHERMAN F, TOMASZEWJSKI, JOSEPH E, SAUSVILLE, EDWARD A and STEVENS, MALCOLM F G, 2002. Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles. Molecular Cancer Therapeutics. 1(4), 239-46

Content
LOAIZA-PÉREZ, ANDREA I, TRAPANI, VALENTINA, HOSE, CURTIS, SINGH, SHEO S, TREPEL, JANE B, STEVENS, MALCOLM F G, BRADSHAW, TRACEY D and SAUSVILLE, EDWARD A, 2002. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole. Molecular Pharmacology. 61(1), 13-9

Content
HEERY, D.M., HOARE, S., HUSSAIN, S., PARKER, M.G. and SHEPPARD, H., 2001. Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors Journal of Biological Chemistry. 276(9), 6695-6702

Content
SHEPPARD, H.M., HARRIES, J.C., HUSSAIN, S., BEVAN, C. and HEERY, D.M., 2001. Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1 Molecular and Cellular Biology. 21(1), 39-50
Displaying 781 to 795 of 914
Previous … 51 52 53 54 55 … Next

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

For all enquiries please visit:
www.nottingham.ac.uk/enquiry